2m 2m 2m 2m 2m 2m 2m
EDGEWISE THERAP (EWTX)
NASDAQ
$43.90-$0.50 (-1.14%)
Price as of Sep 11, 2026 7:30 PM EDT- $4.8BMarket Cap
- 211.80%1-Year Change
- BiotechnologyIndustry
EDGEWISE THERAP (EWTX)
$43.90-$0.50 (-1.14%)
EWTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $44.40 | ||
Change | +$1.50 (+3.50%) | ||
Open | $43.54 | ||
High | $44.80 | ||
Low | $42.90 | ||
Previous Close | $42.90 | ||
Volume | 1,501,972 | ||
30-Day Average Volume | 1,078,567 | ||
1-Week Change | 3.09% | ||
1-Month Change | 0.20% | ||
1-Year Change | 211.80% | ||
3-Year Change | 578.90% | ||
5-Year Change | 175.61% | ||
Fundamentals | |||
Shares Outstanding | 108.6M | ||
Total Assets | $479.7M | ||
Market Cap | $4.8B | ||
Enterprise Value | $4.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$57.3M | ||
Free Cash Flow | -$42.5M | ||
EBIT | -$57.3M | ||
EBITDA | -$56.8M | ||
Net Working Capital | $442.5M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -84 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 11 | ||
P/E | -84 | ||
PEG | 6 | ||
Price/Free Cash Flow | -113 | ||
Price/Operating Cash Flow | -114 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue